Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
190 JPY
7.73 B JPY
75.73 B JPY
17.77 M
About ZERIA PHARMACEUTICAL
Sector
CEO
Sachiaki Ibe
Headquarters
Tokyo
Website
Founded
1955
ISIN
JP3428850006
FIGI
BBG000C1WXD1
Zeria Pharmaceutical Co., Ltd. engages in the manufacture, sale, import and export of pharmaceutical products. It operates through the following segments: Ethical Pharmaceuticals, Consumer Healthcare, and Others. The Ethical Pharmaceuticals segment deals with the research, development, and distribution of medical drugs. The Consumer Healthcare segment manufactures, supplies, and markets self-medication over-the-counter (OTC) drugs, health foods, quasi drugs, and cosmetics. The Others segment includes insurance and real estate businesses. It also develops and distributes agricultural and industrial chemicals, and reagents. The company was founded in December 22, 1955 and is headquartered in Tokyo, Japan.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 4559 is 2,240 JPY — it has increased by 0.86% in the past 24 hours. Watch ZERIA PHARMACEUTICAL stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TSE exchange ZERIA PHARMACEUTICAL stocks are traded under the ticker 4559.
4559 stock has fallen by −3.24% compared to the previous week, the month change is a −5.08% fall, over the last year ZERIA PHARMACEUTICAL has showed a 16.67% increase.
4559 reached its all-time high on Jan 21, 2014 with the price of 3,170 JPY, and its all-time low was 705 JPY and was reached on Mar 15, 2011. View more price dynamics on 4559 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
4559 stock is 1.66% volatile and has beta coefficient of 0.40. Track ZERIA PHARMACEUTICAL stock price on the chart and check out the list of the most volatile stocks — is ZERIA PHARMACEUTICAL there?
Today ZERIA PHARMACEUTICAL has the market capitalization of 97.90 B, it has decreased by −6.65% over the last week.
Yes, you can track ZERIA PHARMACEUTICAL financials in yearly and quarterly reports right on TradingView.
ZERIA PHARMACEUTICAL is going to release the next earnings report on Jan 30, 2025. Keep track of upcoming events with our Earnings Calendar.
4559 net income for the last quarter is 1.85 B JPY, while the quarter before that showed 4.21 B JPY of net income which accounts for −56.12% change. Track more ZERIA PHARMACEUTICAL financial stats to get the full picture.
ZERIA PHARMACEUTICAL dividend yield was 2.06% in 2023, and payout ratio reached 25.09%. The year before the numbers were 1.78% and 28.52% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 13, 2024, the company has 1.78 K employees. See our rating of the largest employees — is ZERIA PHARMACEUTICAL on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ZERIA PHARMACEUTICAL EBITDA is 18.66 B JPY, and current EBITDA margin is 22.81%. See more stats in ZERIA PHARMACEUTICAL financial statements.
Like other stocks, 4559 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ZERIA PHARMACEUTICAL stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ZERIA PHARMACEUTICAL technincal analysis shows the sell today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ZERIA PHARMACEUTICAL stock shows the buy signal. See more of ZERIA PHARMACEUTICAL technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.